Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark is supported by a resilient portfolio anchored in personal care and consumer tissue, with brands like Huggies, Kleenex, and Cottonelle that benefit from steady household demand and strong category leadership. Its geographic diversification across North America, Europe, Asia, and Latin America, plus the professional segment, helps cushion softness in any one market while productivity gains and manageable cost headwinds support expected +1-2% organic sales growth and +1-2% EPS growth in 2026-28. The planned addition of Kenvue’s consumer health portfolio in the second half of calendar year 2026 should broaden its mix and create meaningful longer-term earnings upside, even as near-term integration costs and higher debt weigh on results.

Kimberly-Clark is facing a weaker organic growth profile as North America momentum softened, China has not improved, and management flagged about 2 percentage points of incremental top-line pressure from a postponed innovation launch and inventory de-loading. It is also absorbing roughly $30 million to $50 million of extra freight, logistics, tariff, and input-cost pressure, including a 70 to 80 basis point shipment hit from the California warehouse fire and an estimated ~250 basis point China headwind to 3Q26 top-line momentum. Although the Kenvue deal could add strategic scale in the second half of calendar year 2026, the market’s skepticism around sustainable organic revenue growth and the downward revision to 2026E EPS from $7.40 to $7.30 underscore a still-deteriorating fundamental backdrop.